Literature DB >> 18713570

Donepezil in patients with subcortical vascular cognitive impairment.

Karen Marder.   

Abstract

Entities:  

Year:  2008        PMID： 18713570     DOI： 10.1007/s11910-008-0056-4

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN： 1528-4042            Impact factor:   5.081


× No keyword cloud information.
  10 in total

Review 1.  The rationale behind cholinergic drug treatment for dementia related to cerebrovascular disease.

Authors:  C Grantham; H Geerts
Journal:  J Neurol Sci       Date:  2002-11-15       Impact factor: 3.181

2.  Cholinergic denervation in a pure multi-infarct state: observations on CADASIL.

Authors:  Marsel Mesulam; Teepu Siddique; Bruce Cohen
Journal:  Neurology       Date:  2003-04-08       Impact factor: 9.910

3.  Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia.

Authors:  A Joutel; C Corpechot; A Ducros; K Vahedi; H Chabriat; P Mouton; S Alamowitch; V Domenga; M Cécillion; E Marechal; J Maciazek; C Vayssiere; C Cruaud; E A Cabanis; M M Ruchoux; J Weissenbach; J F Bach; M G Bousser; E Tournier-Lasserve
Journal:  Nature       Date:  1996-10-24       Impact factor: 49.962

4.  Memantine in vascular dementia.

Authors:  Hans Jörg Möbius; Albrecht Stöffler
Journal:  Int Psychogeriatr       Date:  2003       Impact factor: 3.878

5.  The cognitive profiles of CADASIL and sporadic small vessel disease.

Authors:  R A Charlton; R G Morris; A Nitkunan; H S Markus
Journal:  Neurology       Date:  2006-05-23       Impact factor: 9.910

Review 6.  Rivastigmine tartrate with a focus on dementia associated with Parkinson's disease.

Authors:  Keith Wesnes
Journal:  Drugs Today (Barc)       Date:  2007-06       Impact factor: 2.245

7.  Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials.

Authors:  Harish Kavirajan; Lon S Schneider
Journal:  Lancet Neurol       Date:  2007-09       Impact factor: 44.182

8.  White matter hyperintensities and subclinical infarction: associations with psychomotor speed and cognitive flexibility.

Authors:  Clinton B Wright; Joanne R Festa; Myunghee C Paik; Alexis Schmiedigen; Truman R Brown; Mitsuhiro Yoshita; Charles DeCarli; Ralph Sacco; Yaakov Stern
Journal:  Stroke       Date:  2008-02-07       Impact factor: 7.914

9.  Regional white matter pathology in mild cognitive impairment: differential influence of lesion type on neuropsychological functioning.

Authors:  Lisa Delano-Wood; Norm Abeles; Joshua M Sacco; Christina E Wierenga; Nikki R Horne; Andrea Bozoki
Journal:  Stroke       Date:  2008-02-07       Impact factor: 7.914

Review 10.  Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia.

Authors:  Gustavo C Román; Raj N Kalaria
Journal:  Neurobiol Aging       Date:  2005-11-21       Impact factor: 4.673
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.